| scholarly article | Q13442814 |
| P2093 | author name string | Edward K Lobenhofer | |
| C Marcelo Aldaz | |||
| Cynthia A Afshari | |||
| Leping Li | |||
| Pierre R Bushel | |||
| Cheryl Lyn Walker | |||
| Jennifer D Cook | |||
| Lee Bennett | |||
| Leslie C Hodges | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| tamoxifen | Q412178 | ||
| P304 | page(s) | 300-11 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | Molecular Cancer Research | Q2751014 |
| P1476 | title | Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells | |
| P478 | volume | 1 |
| Q35052559 | A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer |
| Q21284776 | AGR2 predicts tamoxifen resistance in postmenopausal breast cancer patients |
| Q34369138 | Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells |
| Q37599164 | Association of Over-Expressed Estrogen Receptor Alpha with Development of Tamoxifen Resistant Hyperplasia and Adenocarcinomas in Genetically Engineered Mice |
| Q33871546 | Building the process-drug-side effect network to discover the relationship between biological processes and side effects |
| Q33287050 | Comparative temporal and dose-dependent morphological and transcriptional uterine effects elicited by tamoxifen and ethynylestradiol in immature, ovariectomized mice |
| Q40636982 | Computational method for discovery of estrogen responsive genes |
| Q36447455 | Differential regulation of native estrogen receptor-regulatory elements by estradiol, tamoxifen, and raloxifene |
| Q34506613 | Downregulation of miR-342 is associated with tamoxifen resistant breast tumors. |
| Q38724038 | Effect of teicoplanin on the expression of c-myc and c-fos proto-oncogenes in MCF-7 breast cancer cell line |
| Q35558050 | Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes |
| Q37061875 | Estrogen directly activates AID transcription and function |
| Q33947874 | Estrogen down-regulation of the corepressor N-CoR: mechanism and implications for estrogen derepression of N-CoR-regulated genes |
| Q36160032 | Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. |
| Q64069811 | HER2 and p95HER2 differentially regulate miRNA expression in MCF-7 breast cancer cells and downregulate MYB proteins through miR-221/222 and miR-503 |
| Q30996844 | Identification and regulation of c-Myb target genes in MCF-7 cells |
| Q34411166 | Identification of gene regulation patterns underlying both oestrogen- and tamoxifen-stimulated cell growth through global gene expression profiling in breast cancer cells. |
| Q36259341 | Induction of Hsp22 (HspB8) by estrogen and the metalloestrogen cadmium in estrogen receptor-positive breast cancer cells |
| Q34122589 | Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element |
| Q38539670 | MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies |
| Q35963023 | Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells |
| Q35040890 | Mechanisms of Gefitinib-mediated reversal of tamoxifen resistance in MCF-7 breast cancer cells by inducing ERα re-expression |
| Q91695710 | Moonlighting Proteins and Cardiopathy in the Spatial Response of MCF-7 Breast Cancer Cells to Tamoxifen |
| Q36603616 | Myb proteins: angels and demons in normal and transformed cells |
| Q34919332 | Nemo-like kinase associated with proliferation and apoptosis by c-Myb degradation in breast cancer |
| Q40462726 | Positive and negative regulation of c-Myb by cyclin D1, cyclin-dependent kinases, and p27 Kip1. |
| Q35603632 | Redox signalling to nuclear regulatory proteins by reactive oxygen species contributes to oestrogen-induced growth of breast cancer cells |
| Q33635621 | Regulation of hormonal therapy resistance by cell cycle machinery |
| Q33553729 | Retracted: Chaperonin CCT-Mediated AIB1 Folding Promotes the Growth of ERα-Positive Breast Cancer Cells on Hard Substrates |
| Q34041328 | Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines |
| Q34355817 | Suppression of Aurora-A oncogenic potential by c-Myc downregulation |
| Q23916703 | Tamoxifen induces expression of immune response-related genes in cultured normal human mammary epithelial cells |
| Q33951695 | The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium |
| Q21245733 | The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention |
| Q52680490 | UBASH3B promotes tamoxifen resistance and could be negatively regulated by ESR1. |
| Q37136871 | Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity |
Search more.